Fentanyl, Heroin Vaccines to Enter Phase 1 Trials Soon
University of Montana
Researchers, partners are working on good manufacturing practices to scale up and support vaccines’ clinical trials
Clinical Trials
Innovations for Equitable Cervical Cancer Screening
Swathi Kodaikal, MSc
Accessible screening tests and inclusive management strategies could reduce cervical cancer globally
FDA Approves First Oral Treatment for Postpartum Depression
U.S. Food and Drug Administration
Multicenter clinical trials demonstrated the efficacy of Zurzuvae in women with PPD
Novel Protein Inhibitor Shows Antitumor Activity in Patients with NHL
Vall d'Hebron Institute of Oncology
Monotherapy with new PRMT5 inhibitor well tolerated with low toxicity in adults with B cell non-Hodgkin lymphomas
FDA Approves New Drug to Prevent RSV in Babies, Toddlers
U.S. Food and Drug Administration
Beyfortus proved to be safe and efficacious in trials with infants at varying degrees of risk for RSV infection
Water: The Heart of Your Drug Formulation Experiments
Marnie Willman, BSc
When generating the optimal formulation, it’s essential to get your water right
Cells and Animals Require High-Grade Water
Marnie Willman, BSc
Impure or contaminated water can negatively affect your model experiments
Tumor Monocyte Content May Better Predict ICI Therapy Outcomes
Ludwig Cancer Research
Patients with high TMC may generate more proinflammatory immune cells, and therefore, respond better to immunotherapy
Dual Immunotherapy May Effectively Treat Recurrent or Metastatic NPC
SingHealth
Nivolumab/ipilimumab immunotherapy showed results comparable to response rates and survival benefits conferred by chemotherapy
NIH’s ComboMATCH to Test New Drug Combinations Guided by Tumor Biology
National Institutes of Health
ComboMATCH comprises several Phase 2 treatment trials that will each evaluate a drug combination plus a chemotherapy drug